MENU
CNSP
AS OF
Dec 12 closing price
Price
$7.79
Change
+$0.14 (+1.83%)
Capitalization
4.83M
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
CNSP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

CNS Pharmaceuticals (CNSP) Ownership - Who owns CNS Pharmaceuticals?

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
2100 West Loop South
Phone
+1 800 946-9185
Employees
5
Web
https://www.cnspharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.83M
P/E Ratio
0.01
Total Cash
9.86M
Projected Growth
N/A
Total Debt
30.79K
Revenue
N/A
Risk (Beta)
1.43
Dividend Yield
N/A
Total Cash/Share
15.90
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

CNSP
Capitalization
4.83M
P/E Ratio
0.01
Risk (Beta)
1.43
Dividend Yield
N/A
Total Cash
9.86M
Total Cash/Share
15.90
Total Debt
30.8K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
9.91M
P/B Ratio
0.49
Cash Flow
N/A
Earnings
776.03
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
574
Current Ratio
5.81
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-13.05M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-135.60
Shares Held By Institutions
243K
Shares Outstanding - Current
620K
Total Liabilities
1.96M
Total Volume MTD
N/A
Value
1
Gain YTD
-89.405
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CNSP
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
View AI-Driven Trading for CNSP
A.I. Advisor
published General Information

General Information

a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2100 West Loop South
Phone
+1 800 946-9185
Employees
5
Web
https://www.cnspharma.com